Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors

Summary

This study is a single-arm early exploratory clinical study. designed to evaluate the safety and tolerability of GT201 in combination with a PD-1 inhibitor for the treatment of advanced head and neck tumor subjects with safety and tolerability, as well as pharmacokinetic characterization and efficacy The study consists of two phases. The study consists of two phases, a dose-escalation phase and a dose-expansion phase.

Timeline

Start

2024-05-12

Primary completion

2027-04-30

Completion

2027-04-30

Drugs

Indications